Comparison of the efficacy and safety of hybrid and sequential therapies as a first-line regimen for Helicobacter pylori infection in Turkey.
Conclusions: Both therapies are highly effective for eradication of H. pylori, and could be recommended as a first-line therapy in regions with high antibiotic resistance.
PMID: 29593799 [PubMed]
Source: Archives of Medical Science - Category: Biomedical Science Tags: Arch Med Sci Source Type: research
More News: Amoxicillin | Biaxin | Biomedical Science | Clarithromycin | Drugs & Pharmacology | Helicobacter Pylori | Metronidazole | Middle East Health | Science | Study | Turkey Health